Roche, the Swiss pharmaceutical group, is funding a study to test the efficacy of its flu drug Tamiflu in combination with rival GlaxoSmithKline's Relenza, in one of several initiatives to extend further the market for its blockbuster antiviral treatment.
瑞士制药集团罗氏(Roche)正为一项研究提供资金，以测试其抗流感药物达菲(Tamiflu)与竞争对手葛兰素史克(GlaxoSmithKline)的乐感清(Relenza)结合使用的疗效。这是罗氏为其畅销抗病毒药物扩展市场的又一项举措。
您已阅读16%（374字），剩余84%（2012字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。